Stay updated on Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.

Latest updates to the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.2 to v3.8.0. The study record content remains unchanged.SummaryDifference0.1%

- Check16 days agoChange DetectedA notice announces changes to NIH websites and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.5%

- Check23 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check30 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check51 days agoChange DetectedA new site revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed. This reflects an update to the page's release notes rather than changes to trial information.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the Record History page, reflecting a new internal build. This change is metadata and does not alter study data or visible page content.SummaryDifference0.1%

Stay in the know with updates to Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.